These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 62002)

  • 1. The demonstration of cell-associated immunity to viruses. In vitro lymphocyte responsiveness to Varicella-zoster antigen.
    Ruckdeschel JC; Mardiney MR
    J Immunol Methods; 1976; 13(2):131-43. PubMed ID: 62002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease.
    Ruckdeschel JC; Schimpff SC; Smyth AC; Mardiney MR
    Am J Med; 1977 Jan; 62(1):77-85. PubMed ID: 189604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
    Naganuma M; Nagahori M; Fujii T; Morio J; Saito E; Watanabe M
    Inflamm Bowel Dis; 2013 Feb; 19(2):418-22. PubMed ID: 22605673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.
    Berger R; Florent G; Just M
    Infect Immun; 1981 Apr; 32(1):24-7. PubMed ID: 6163722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: in vitro studies of possible mechanisms.
    Giller RH; Bowden RA; Levin MJ; Walker LJ; Tubergen DG; Hayward AR
    J Clin Immunol; 1986 Nov; 6(6):472-80. PubMed ID: 3023433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity to varicella zoster virus in children being treated for cancer.
    Hayes FA; Feldman S
    Cancer; 1978 Jul; 42(1):159-63. PubMed ID: 208747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer factor and cellular reactivity to varicella-zoster antigen in childhood leukemia.
    Steele RW
    Cell Immunol; 1980 Mar; 50(2):282-9. PubMed ID: 6244113
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of HLA on the cellular immune response to varicella-zoster virus.
    Chiba Y; Miura J; Nakao T; Wakisaka A; Kunikane K
    Biken J; 1985 Jun; 28(1-2):1-7. PubMed ID: 3000347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Infect Dis; 1978 May; 137(5):531-40. PubMed ID: 207782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients.
    Arvin AM; Pollard RB; Rasmussen LE; Rand KH; Merigan TC
    IARC Sci Publ (1971); 1978; (24 Pt 2):745-51. PubMed ID: 221398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of immunity to varicella-zoster virus by means of an intradermal skin test.
    LaRussa P; Steinberg SP; Seeman MD; Gershon AA
    J Infect Dis; 1985 Nov; 152(5):869-75. PubMed ID: 2995511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte response to virus antigens in systemic lupus erythematosus.
    Wolf RE; Ziff M
    Arthritis Rheum; 1976; 19(6):1271-7. PubMed ID: 187203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
    Milikan JC; Kinchington PR; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyporesponsiveness of lymphocytes to virus antigens in rheumatoid arthritis.
    Wolf RE
    Arthritis Rheum; 1978 Mar; 21(2):238-42. PubMed ID: 205223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
    Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
    J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity to varicella-zoster virus: in vitro lymphocyte responses.
    Jordan GW; Merigan TC
    J Infect Dis; 1974 Nov; 130(5):495-501. PubMed ID: 4370611
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.
    Bergen RE; Diaz PS; Arvin AM
    J Infect Dis; 1990 Nov; 162(5):1049-54. PubMed ID: 2172393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.